DONALD STONE: Open Payments
NPI 1104879915 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 18 payments from 6 companies in 2025. Trend: 2023 $53 · 2024 $398 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $162 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $100 |
| Regeneron Healthcare Solutions, Inc. | 4 | $93 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $27 |
Products named: NEFFY, DUPIXENT, XOLAIR, Rhapsido, TEZSPIRE, EOHILIA, EBGLYSS.
Industry payments across TX — which companies pay providers there.
